|
05 Sep 2018 |
Inovio Doses 1st Subject in Phase 1/2 Clinical Trial For Vaccine Against Deadly MERS Infection
|
|
04 Sep 2018 |
Advaxis Licenses ADXS-HER2 to OS Therapies for Evaluation in the Treatment of Osteosarcoma
|
|
04 Sep 2018 |
Inovio and Korean Partner Dose 1st Subject In Trial to Develop World’s First Vaccine to Prevent Hepatitis C Infection
|
|
31 Aug 2018 |
Altimmune Announces Initial Single-Dose Data from Its NasoShield Phase 1 Study
|
|
30 Aug 2018 |
Morphogenesis, Inc Celebrates Advancement into Human Clinical Trials
|
|
29 Aug 2018 |
Gradalis® Announces Initiation of Phase 3 Study of Vigil™ in Ewing’s sarcoma
|
|
27 Aug 2018 |
A Specific Active ImmunoTherapy (SAIT) to control cholesterol levels in blood
|
|
22 Aug 2018 |
ALK submits registration application for tree SLIT-tablet in Europe
|
|
21 Aug 2018 |
Initiation of Biosceptre's Phase 1 Clinical Trial for First-in-Class Oncology Vaccine BIL06v
|
|
21 Aug 2018 |
AC Immune Announces Important Clinical Milestones for ACI-24 Vaccine in Alzheimer's Disease and Down Syndrome
|
|
16 Aug 2018 |
Inovio Treats First Patient in Immuno-Oncology Study for Advanced or Metastatic Bladder Cancer in Combination with Roche/Genentech’s Atezolizumab
|
|
16 Aug 2018 |
BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza
|
|
14 Aug 2018 |
Inovio Announces First Patient Dosed in Trial to Determine PENNVAX®-GP’s Ability to Induce Remission of HIV Infection
|
|
09 Aug 2018 |
First Participant Enrolled in BiondVax's Universal Flu Vaccine Pivotal Phase 3 Clinical Trial
|
|
09 Aug 2018 |
OncoPep Announces a Phase 1b Clinical Trial of Its Multi-Peptide Cancer Vaccine PVX-410 in Combination with Citarinostat for Smoldering Multiple Myeloma
|
|
08 Aug 2018 |
Bavarian Nordic Announces Positive Data from Phase 2 Extension Study of its Universal RSV Vaccine
|
|
30 Jul 2018 |
Advaxis Announces FDA Allowance of IND Application for ADXS-HOT Drug Candidate for Non-Small Cell Lung Cancer
|
|
19 Jul 2018 |
Bristol-Myers Squibb and Gritstone Oncology Announce Clinical Research Collaboration to Evaluate Novel Immunotherapy Approach in Advanced Solid Tumors
|
|
13 Jul 2018 |
Advaxis Announces FDA Lifts Clinical Hold on Phase 1/2 Combination Study of Axalimogene Filolisbac with Durvalumab
|
|
11 Jul 2018 |
Bavarian Nordic Announces Initiation of Phase 2 Trial Evaluating the Combination Therapy of CV301 and Nivolumab in Metastatic Colorectal Cancer
|
|
03 Jul 2018 |
Neovacs announces the results of its phase IIb study for IFNalpha kinoid in the treatment of lupus which allows to proceed with the clinical development into phase III
|
|
27 Jun 2018 |
Inovio’s MERS Vaccine Generates High Levels of Antibodies and Induces Broad-based T Cell Responses in Phase 1 Study
|
|
21 Jun 2018 |
Inovio Announces Treatment of First Patient in Immuno-Oncology Study for Glioblastoma (GBM) with INO-5401 in Combination with Regeneron’s PD-1 Inhibitor
|
|
21 Jun 2018 |
AIVITA Biomedical Announces U.S. Food and Drug Administration Clearance of IND for Phase II Glioblastoma Multiforme Trial
|
|
20 Jun 2018 |
OncBioMune to Commence Phase 2 Trial of ProscaVax for Early Stage Prostate Cancer Patients
|
